WFG Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

WFG Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$0	Hold	75	–	–	﹤0.01%	1774
2017 Q1	$0	Hold	75	–	–	﹤0.01%	1782
2016 Q4	$0	Hold	75	–	–	﹤0.01%	1876
2016 Q3	$0	Hold	75	–	–	﹤0.01%	1800
2016 Q2	$0	Hold	75	–	–	﹤0.01%	1814
2016 Q1	$0	Hold	75	–	–	﹤0.01%	1808
2015 Q4	$0	Hold	75	–	–	﹤0.01%	1783
2015 Q3	$0	Hold	75	–	–	﹤0.01%	1830
2015 Q2	$0	Hold	75	–	–	﹤0.01%	1933
2015 Q1	$0	Hold	75	–	–	﹤0.01%	2298
2014 Q4	$0	Hold	75	–	–	﹤0.01%	2387
2014 Q3	$0	Hold	75	–	–	﹤0.01%	2252
2014 Q2	$0	Hold	75	–	–	﹤0.01%	2185
2014 Q1	$0	Hold	75	–	–	﹤0.01%	2446
2013 Q4	$0	Hold	75	–	–	﹤0.01%	2442
2013 Q3	$0	Hold	75	–	–	﹤0.01%	2396
2013 Q2	$0	Buy	+75	New	+$132	﹤0.01%	2172

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Brigade Capital Management New York $1.26B AUM 194.27% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

WFG Advisors's GCVRZ Position: Q2 2017 in Review

WFG Advisors held its Sanofi Contingent Value Rights (GCVRZ) position steady in Q2 2017 at 75 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

WFG Advisors first reported a position in GCVRZ in Q2 2013 and has held it in 17 quarters since. 115 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2017.

WFG Advisors held 75 shares of Sanofi Contingent Value Rights worth $0 as of Q2 2017.
WFG Advisors left its Sanofi Contingent Value Rights share count unchanged in Q2 2017.
Sanofi Contingent Value Rights made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1774 holding.
WFG Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 17 quarters since.
115 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.